We are GREBT, Committed to
a healthier world for all through smarter,
more accessible diagnostic innovation.

Established in 2019, GREBT is a bio-health technology company that has strengthened its
capabilities through collaboration with universities and government-funded research institutes.
We continue to expand our technological foundation and work toward the commercialization
of diverse in-vitro diagnostic systems.

In addition, we are developing differentiated diabetes measurement platforms—such as
CGM sensors, devices, and multi-parameter assessment systems—by advancing core materials
and technologies. Through these innovations, we aim to lead the era of personalized diagnostics
and next-generation in-vitro diagnostic platforms.